Flosonics Raises $5 Million for Device Helping Hospitals Track Critically-ill Patients

January 29 2018

By Betakit

Sudbury-based FloSonics Medical has raised $5 million in funding led by iGan Partners.

Other investors include Genesys Capital, MaRS Investment Accelerator Fund (IAF), Accel-RX, MaRS Catalyst, Angel One, and Northern Ontario Angels.

“We’re very enthusiastic about the investors who partnered in the current financing round lead by iGan Partners. It marks a critical step in the commercial development of our proprietary FloPatch technology,” said Joe Eibl, CEO and co-founder of FloSonics Medical. “Our company is developing a non-invasive means of monitoring critically ill patients during the early stages of shock inside and outside the hospital.”

(